Intrust Bank NA Cuts Stake in HCA Healthcare, Inc. (NYSE:HCA)

Intrust Bank NA decreased its position in HCA Healthcare, Inc. (NYSE:HCA) by 0.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 60,430 shares of the company’s stock after selling 130 shares during the period. HCA Healthcare accounts for about 1.9% of Intrust Bank NA’s investment portfolio, making the stock its 8th biggest position. Intrust Bank NA’s holdings in HCA Healthcare were worth $16,357,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the company. Parkside Financial Bank & Trust boosted its holdings in shares of HCA Healthcare by 8.2% in the fourth quarter. Parkside Financial Bank & Trust now owns 461 shares of the company’s stock valued at $125,000 after purchasing an additional 35 shares during the period. Wedmont Private Capital lifted its holdings in HCA Healthcare by 1.6% during the fourth quarter. Wedmont Private Capital now owns 2,527 shares of the company’s stock worth $711,000 after buying an additional 39 shares during the period. Creative Financial Designs Inc. ADV lifted its holdings in HCA Healthcare by 19.9% during the fourth quarter. Creative Financial Designs Inc. ADV now owns 253 shares of the company’s stock worth $68,000 after buying an additional 42 shares during the period. Huntington National Bank lifted its holdings in HCA Healthcare by 0.4% during the third quarter. Huntington National Bank now owns 11,206 shares of the company’s stock worth $2,756,000 after buying an additional 44 shares during the period. Finally, Perigon Wealth Management LLC lifted its holdings in HCA Healthcare by 2.6% during the fourth quarter. Perigon Wealth Management LLC now owns 1,759 shares of the company’s stock worth $476,000 after buying an additional 44 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock traded up $3.84 on Monday, hitting $310.53. The company’s stock had a trading volume of 869,687 shares, compared to its average volume of 1,104,417. The company has a debt-to-equity ratio of 29.26, a quick ratio of 1.02 and a current ratio of 1.16. HCA Healthcare, Inc. has a 1 year low of $215.96 and a 1 year high of $335.83. The company has a market capitalization of $82.13 billion, a price-to-earnings ratio of 15.52, a price-to-earnings-growth ratio of 1.48 and a beta of 1.65. The firm has a fifty day moving average price of $323.94 and a 200-day moving average price of $295.45.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.01 by $0.35. The company had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. HCA Healthcare’s revenue was up 11.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $4.93 EPS. As a group, sell-side analysts anticipate that HCA Healthcare, Inc. will post 20.58 earnings per share for the current fiscal year.

HCA Healthcare declared that its Board of Directors has approved a share repurchase program on Tuesday, January 30th that permits the company to buyback $6.00 billion in shares. This buyback authorization permits the company to buy up to 7.4% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s management believes its stock is undervalued.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.85%. The ex-dividend date is Friday, June 14th. HCA Healthcare’s payout ratio is presently 13.16%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Kathryn A. Torres sold 3,861 shares of the business’s stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $307.00, for a total value of $1,185,327.00. Following the sale, the senior vice president now owns 15,899 shares of the company’s stock, valued at $4,880,993. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, SVP Chad J. Wasserman sold 876 shares of the company’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total transaction of $289,299.00. Following the sale, the senior vice president now owns 1,576 shares of the company’s stock, valued at $520,474. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Kathryn A. Torres sold 3,861 shares of the company’s stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $307.00, for a total value of $1,185,327.00. Following the sale, the senior vice president now directly owns 15,899 shares in the company, valued at approximately $4,880,993. The disclosure for this sale can be found here. Insiders have sold a total of 14,840 shares of company stock valued at $4,588,869 over the last quarter. 1.70% of the stock is owned by company insiders.

Analyst Ratings Changes

Several analysts have recently commented on HCA shares. Raymond James increased their price objective on HCA Healthcare from $300.00 to $330.00 and gave the company an “outperform” rating in a report on Wednesday, January 31st. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, April 22nd. Royal Bank of Canada increased their price objective on HCA Healthcare from $322.00 to $329.00 and gave the company an “outperform” rating in a report on Monday. Wells Fargo & Company upped their target price on HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research report on Thursday, March 28th. Finally, Truist Financial upped their target price on HCA Healthcare from $320.00 to $345.00 and gave the company a “buy” rating in a research report on Wednesday, January 31st. Four equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $313.88.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.